At TGen, our research focuses on the identification of genes that are involved in the development of diabetes, diabetic kidney disease, cardiovascular disease, and obesity using state-of-the-art technologies. Using this approach, we have successfully identified genes with substantial effects on susceptibility to end-stage kidney failure in diabetes, regulation of cholesterol and lipid levels, and the degree to which individuals respond to diabetes medications with an improvement in insulin sensitivity.
Link to this comment:
All Comments (0)